Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects | |
Gong, Shiqiang; Han, Xiaowan; Li, Xuehong; Yang, Jun; He, Xiaobo; Si, Shuyi | |
2016 | |
卷号 | 21期号:7页码:738-748 |
关键词 | osteoprotegerin (OPG) receptor activator of NF-B ligand (RANKL) high-throughput screening (HTS) osteoporosis |
ISSN号 | 1087-0571 |
DOI | 10.1177/1087057116654657 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6383802 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Gong, Shiqiang,Han, Xiaowan,Li, Xuehong,et al. Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects[J],2016,21(7):738-748. |
APA | Gong, Shiqiang,Han, Xiaowan,Li, Xuehong,Yang, Jun,He, Xiaobo,&Si, Shuyi.(2016).Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects.,21(7),738-748. |
MLA | Gong, Shiqiang,et al."Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects".21.7(2016):738-748. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论